Silverback Therapeutics

• market

  STOCKS

• industry

  Biopharmaceuticals

• website

  silverbacktx.com

• ipo date

  Dec 03, 2020

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorpo...Show More